Sarah Mathieson | Senior Vice President, Corporate Affairs |
David Cory | President and CEO |
Sri Ryali | Chief Financial Officer |
Eldon Mayer | Chief Commercial Officer |
Ingrid Choong | Senior Vice President, Clinical Development |
Colin Hislop | Senior Vice President, Clinical & Development Operations |
Colleen Craig | Vice President, Metabolic Diseases |
Maury Raycroft | Jefferies |
Charlie Moore | Baird |
Bert Hazlett | BTIG |
Farhana Sakloth | Ladenburg |
Welcome to the Eiger BioPharmaceuticals Third Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time [Operator Instructions].
As a reminder, this call will be recorded. I would now like to turn the call over to Sarah Mathieson, Senior Vice President, Corporate Affairs at Eiger.